EAM
Exane Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-12,011
| Closed | -$669K | – | 17 |
|
|
2020
Q1 | $669K | Sell |
12,011
-19,578
| -62% | -$1.09M | 1.31% | 11 |
|
|
2019
Q4 | $2.03M | Sell |
31,589
-171,268
| -84% | -$11M | 2.49% | 11 |
|
|
2019
Q3 | $10.3M | Sell |
202,857
-32,613
| -14% | -$1.65M | 7.9% | 2 |
|
|
2019
Q2 | $10.7M | Sell |
235,470
-78,425
| -25% | -$3.56M | 4.74% | 6 |
|
|
2019
Q1 | $15M | Buy |
313,895
+255,502
| +438% | +$12.2M | 7.29% | 3 |
|
|
2018
Q4 | $3.04M | Sell |
58,393
-266,748
| -82% | -$13.9M | 1.78% | 13 |
|
|
2018
Q3 | $20.2M | Sell |
325,141
-50,696
| -13% | -$3.15M | 6.32% | 1 |
|
|
2018
Q2 | $20.8M | Sell |
375,837
-145,669
| -28% | -$8.06M | 9% | 2 |
|
|
2018
Q1 | $33M | Buy |
521,506
+138,180
| +36% | +$8.74M | 9.9% | 1 |
|
|
2017
Q4 | $23.5M | Sell |
383,326
-90,435
| -19% | -$5.54M | 7.3% | 4 |
|
|
2017
Q3 | $30.2M | Sell |
473,761
-80,601
| -15% | -$5.14M | 5.9% | 4 |
|
|
2017
Q2 | $30.9M | Buy |
554,362
+34,226
| +7% | +$1.91M | 9.63% | 1 |
|
|
2017
Q1 | $28.3M | Buy |
520,136
+244,907
| +89% | +$13.3M | 8.77% | 2 |
|
|
2016
Q4 | $16.1M | Buy |
275,229
+134,704
| +96% | +$7.87M | 5.3% | 8 |
|
|
2016
Q3 | $7.58M | Buy |
+140,525
| New | +$7.58M | 2.38% | 21 |
|